Christopher F Bryang
Research Subjects
Christopher F Bryang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Daniel Murillo
University of Kansas Medical Center, Kansas City, KS
2 shared publicationsAlan M. Luger
University Hospital, Columbia, MO
1 shared publicationBradley A Warady
1 shared publicationBradley A. Warady
Children's Mercy Hospital, Kansas City, MO
1 shared publicationCharles F Shield
1 shared publicationCharles F. Shield
1 shared publication
Latest Publications
- 10 June 2003
- Published by Wiley in Clinical Transplantation
- Vol. 17 (s9) , 58-64
Cold ischaemia time added to kidneys can be minimized by completing the final cross‐match before organs are taken from the operating room
Abstract: Purpose: Minimizing the amount of cold ischaemia time (CIT) added to cadaveric kidneys before their transplantation is an important goal since longer CIT is associated with worse long‐term graft outcome. Our organ procurement organization (OPO) and HLA laboratories have taken the approach of performing the histocompatibility testing, including the final cross‐match, as early in the donor process as possible.Methods: The data in this study were collected from all consecutive final cross‐matches done for cadaveric kidney (n = 113) and simultaneous pancreas + kidney (SPK) (n = 25) transplants done with organs recovered from donors in the Midwest Transplant Network OPO from 1 January 2001 to 9 May 2002. We evaluated the time the final cross‐match was completed from when the kidneys from that donor were taken from the operating room (OR) and compared that time with CIT.Results: For kidney transplants, 72% of the final cross‐matches were complete before the kidneys were taken from the OR. The CIT of that group (10.4 ± 3.8 h) was significantly lower than that of the group of kidney transplant patients whose final cross‐match was done after the kidneys were taken from the OR (15.5 ± 5.8 h) (P < 0.001). Similarly, for SPK transplants, 88% of the final cross‐matches were completed before the organs left the OR and the CIT of that group (10.2 ± 3.4 h) was less than in the group whose final cross‐match was done after the organs left the OR (14.3 ± 4.8 h) (P > 0.1).Conclusions: These data show that the practice of completing the final cross‐match as early in the donor process as possible helps to minimize the amount of cold ischaemia time added to the kidneys and pancreata before transplantation. That should reduce the detrimental influence that longer CIT has on short‐ and long‐term function in kidney as well as SPK transplantation.
- 10 June 2003
- Published by Wiley in Clinical Transplantation
- Vol. 17 (s9) , 58-64
Cold ischaemia time added to kidneys can be minimized by completing the final cross‐match before organs are taken from the operating room
Abstract: Purpose: Minimizing the amount of cold ischaemia time (CIT) added to cadaveric kidneys before their transplantation is an important goal since longer CIT is associated with worse long‐term graft outcome. Our organ procurement organization (OPO) and HLA laboratories have taken the approach of performing the histocompatibility testing, including the final cross‐match, as early in the donor process as possible.Methods: The data in this study were collected from all consecutive final cross‐matches done for cadaveric kidney (n = 113) and simultaneous pancreas + kidney (SPK) (n = 25) transplants done with organs recovered from donors in the Midwest Transplant Network OPO from 1 January 2001 to 9 May 2002. We evaluated the time the final cross‐match was completed from when the kidneys from that donor were taken from the operating room (OR) and compared that time with CIT.Results: For kidney transplants, 72% of the final cross‐matches were complete before the kidneys were taken from the OR. The CIT of that group (10.4 ± 3.8 h) was significantly lower than that of the group of kidney transplant patients whose final cross‐match was done after the kidneys were taken from the OR (15.5 ± 5.8 h) (P < 0.001). Similarly, for SPK transplants, 88% of the final cross‐matches were completed before the organs left the OR and the CIT of that group (10.2 ± 3.4 h) was less than in the group whose final cross‐match was done after the organs left the OR (14.3 ± 4.8 h) (P > 0.1).Conclusions: These data show that the practice of completing the final cross‐match as early in the donor process as possible helps to minimize the amount of cold ischaemia time added to the kidneys and pancreata before transplantation. That should reduce the detrimental influence that longer CIT has on short‐ and long‐term function in kidney as well as SPK transplantation.
- Open Access
- 1 April 2003
- Published by Elsevier in American Journal of Transplantation
- Vol. 3 (4) , 459-464
HLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors
The points now assigned for the quality of HLA match have received significant scrutiny to be modified in an effort to help reduce disparity in access to kidneys of minority groups, and since differences in graft survival between groups of patients in each of the HLA matched groups is less now than in the past. We analyzed long-term (5-year) graft survival in 746 DR DNA typed recipients of cadaveric kidneys transplanted from 1994-2001 whose donors were also DR DNA typed, with allocation based on those DNA-based typings. Five-year graft survival was not significantly different for recipient groups irrespective of if they had zero (84%), one (92%), two (89%), or three to four B, DR mismatches (79%) (log-rank = 0.15; died with a functioning graft [DWFG] censored). Mismatching of three and four DR and DQ antigens in black but not white patients was associated with significantly worse survival (Relative Risk = 2.9) (p = 0.002). The incidence of minority transplants in the well-matched group (zero and one B, DR mismatch), 12.8% (20/156) was over half that of the less well-matched group, 27.1% (160/590) (p < 0.001). Our data indicate that the current HLA-B, DR-based point system used to allocate kidneys warrants re-evaluation. Our data, taken in the context of the UNOS data, which has recently been re-evaluated, suggest that the only HLA-DR remain as a component of the national kidney allocation algorithm so as to increase access of kidneys to minorities and minimize graft loss.
- 1 April 2003
- Published by Elsevier in American Journal of Transplantation
- Vol. 3 (4) , 459-464
Open AccessHLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors
The points now assigned for the quality of HLA match have received significant scrutiny to be modified in an effort to help reduce disparity in access to kidneys of minority groups, and since differences in graft survival between groups of patients in each of the HLA matched groups is less now than in the past. We analyzed long-term (5-year) graft survival in 746 DR DNA typed recipients of cadaveric kidneys transplanted from 1994-2001 whose donors were also DR DNA typed, with allocation based on those DNA-based typings. Five-year graft survival was not significantly different for recipient groups irrespective of if they had zero (84%), one (92%), two (89%), or three to four B, DR mismatches (79%) (log-rank = 0.15; died with a functioning graft [DWFG] censored). Mismatching of three and four DR and DQ antigens in black but not white patients was associated with significantly worse survival (Relative Risk = 2.9) (p = 0.002). The incidence of minority transplants in the well-matched group (zero and one B, DR mismatch), 12.8% (20/156) was over half that of the less well-matched group, 27.1% (160/590) (p < 0.001). Our data indicate that the current HLA-B, DR-based point system used to allocate kidneys warrants re-evaluation. Our data, taken in the context of the UNOS data, which has recently been re-evaluated, suggest that the only HLA-DR remain as a component of the national kidney allocation algorithm so as to increase access of kidneys to minorities and minimize graft loss.
- Open Access
- 1 January 2002
- Published by Elsevier in American Journal of Transplantation
- Vol. 2 (1) , 94-99
Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System?
Since blood group B end‐stage renal disease (ESRD) patients have less access to donor kidneys and a higher minority composition than any other blood group, the United Network for Organ Sharing (UNOS)...
- 1 January 2002
- Published by Elsevier in American Journal of Transplantation
- Vol. 2 (1) , 94-99
Open AccessIncreased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System?
Since blood group B end‐stage renal disease (ESRD) patients have less access to donor kidneys and a higher minority composition than any other blood group, the United Network for Organ Sharing (UNOS)...